Was this page useful?

*Required Field

Research / News & Events/ News





« Back to listings
Photo: Dr. Jack Gauldie, the new Vice President, Research Institute at St. Joseph's Healthcare Hamilton, is as diverse in accomplishments as he is world-renowned in his field of study. He attended Delta Secondary School in Hamilton's east end, and was also a water polo Olympian and CBCSports commentator.

It is with great pleasure that the Research Institute of St. Joseph's Healthcare Hamilton announces the appointment of Dr. Jack Gauldie as its new Vice President of Research.

Dr. Gauldie brings to this role an extensive career of scientific investigation, specifically exploring the body’s immune responses to disease.  His primary area of focus, molecular manipulation for the treatment of diseases including cancer, arthritis and chronic lung diseases, has earned him international recognition as a leading expert in the field of gene therapeutics.  His commitment to patient driven research, geared to improving quality of life, aligns with the goals of St. Joe’s Research Institute, making him the ideal candidate to advance the organization’s mandate.

Regarding his appointment, Dr. Gauldie noted: “St Joseph’s is known world-wide for its research and clinical excellence, especially in lung disease. This excellence is something we want to preserve and expand along with the other areas of outstanding clinical leadership and research that identify St Joe’s as a well-respected academic health sciences institution. The recent successful expansion of the West 5th Campus and the establishment of the new Research Institute gives me confidence that the administration and hospital as a whole are committed to delivering upon excellence in research.  There are a number of goals to define, faculty and staff energy and intellect to capture, and needs to provide world-class facilities to deliver on the promise of research progress to better human health.”

St Joseph’s has much to offer to achieve these goals; outstanding staff, solid administration and an intellectual drive for academic excellence. Together with our colleagues at Hamilton Health Sciences and McMaster University, we can derive great benefit for the health of the people of Hamilton and Canada. I am looking forward to work with the many talented people in the hospital system and I will enjoy seeing promises and progress come to fruition.”

“We are delighted that Dr. Gauldie has accepted this role,” said Dr. Kevin Smith, President and CEO of the St. Joseph’s Health System. “A world renowned expert, Jack has contributed greatly to Canada, and Hamilton’s reputation for being on the leading edge of the world in his field. He is the perfect candidate to lead St. Joseph’s onto that same stage.”

Dr. David Higgins, President of St. Joseph’s Healthcare Hamilton noted that Dr. Gauldie’s past work on advisory Boards like the Canadian Institutes for Health Research and current position as Chair of the Advisory Board of the Ontario Research fund will be invaluable as St. Joseph’s strives to build its prominence as one of the top research institutes in the country. “In addition to his wealth of knowledge, Dr. Gauldie is also very well respected by the St. Joseph’s research community. The Research Institute Board is thrilled with his appointment.”

“This is good news all around. Jack Gauldie has a solid reputation as one of McMaster University’s most senior and highly cited scientists, and he holds our highest academic honour as a Distinguished University Professor,” said Dr. John Kelton, dean and vice-president of McMaster’s Faculty of Health Sciences. “Dr. Gauldie is a leader at the national and international levels for his expertise in evaluating science and developing interdisciplinary research teams, and this excellence will ensure a wonderful future for the research mandate of our academic hospital partner St. Joseph’s Healthcare Hamilton.”

Dr. Gauldie has published over 370 scientific articles and a number of book chapters, mainly dealing with the areas of biomedical research. He has received awards from the Canadian Medical Association, the Canadian Society of Clinical Chemists, and the Canadian Society for Immunology. 

Comments are closed.